about
Transforming growth factor-beta1 down-regulation of major histocompatibility complex class I in thyrocytes: coordinate regulation of two separate elements by thyroid-specific as well as ubiquitous transcription factorsThe p85α regulatory subunit of PI3K mediates cAMP-PKA and retinoic acid biological effects on MCF7 cell growth and migration.HE4 in the differential diagnosis of a pelvic mass: a case report.Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer.The role of peroxiredoxins in cancer.PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma.Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer.Effects of the Smad4 C324Y mutation on thyroid cell proliferation.A novel human Smad4 mutation is involved in papillary thyroid carcinoma progression.Role of reduced expression of SMAD4 in papillary thyroid carcinoma.Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.The phosphatase inhibitor okadaic acid stimulates the TSH-induced G1-S phase transition in thyroid cells.Transforming growth factor beta regulates differentiation and proliferation of human neuroblastoma.Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: a case report.EGF and TGF-β1 Effects on Thyroid Function.Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14.PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms.Peroxiredoxin 2 nuclear levels are regulated by circadian clock synchronization in human keratinocytes.Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition.Contribution of Variants to Male Breast Cancer Risk: Results From a Multicenter Study in ItalyMRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumorsNext-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancerA Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal CancerIncreased type II transforming growth factor-beta receptor expression in liver cells during cholesterol challengeThe p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signalsA complex pattern of mutations and abnormal splicing of Smad4 is present in thyroid tumoursCoexistence of three EGFR mutations in an NSCLC patient: A brief reportIdentification of novel BRCA1 large genomic rearrangements by a computational algorithm of amplicon-based Next-Generation Sequencing dataEvaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer riskSMO-M2 mutation does not support cell-autonomous Hedgehog activity in cerebellar granule cell precursorsClinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer
P50
Q28570761-E07291F6-1CF8-459C-A36E-9676E8F60CAEQ30010160-88EF3B81-BAAD-4848-B981-2591B54AE265Q34578148-03B04AF1-59DB-453A-99D9-F642BF97DA10Q37233477-E1C6C6B3-90EB-4898-93DE-7C93648572EDQ37701814-0EC21641-7E97-4802-8E39-326246A55B2CQ38844568-E770F86A-F4AC-48CD-BDBB-5684C2B2D5E2Q39018250-E8A4E64A-8265-4340-B607-E20B1224C8BDQ39165289-7E2C6801-F077-40B7-AF4B-1AD630CD9393Q39438445-ED7175D0-52AD-4A78-B4BE-B4A56005E52BQ39671353-4CA43459-DE3B-413F-AB4E-DBF07C4E5BDEQ40573572-885C0E5B-1A62-480E-BED0-E5E24AF81DBBQ41097370-2F11A373-3443-49E6-B6F7-D61F744B8983Q41150176-2AF3DDB1-266D-4AF0-969B-DA135955B844Q41852171-F5E8A6CB-7609-4549-A0F1-FA5BA9F4E389Q42795692-A0F6381B-9448-41A6-8678-812A901139C9Q44556540-F571FCEE-200B-47E6-8BDF-281F5DF85BBCQ46022493-0269CC8B-16FE-47E2-9D7E-581C9CAA51C9Q46895748-B45125F2-E9E2-4738-8A4C-DFF3E0257681Q55436305-C3439F80-03DA-4BDB-B147-3FB96CDD3704Q60046965-A176765E-7A07-453A-ADF9-03A14B85B1F1Q61631672-96CC9B11-D48A-4CCB-991E-44035DFAE700Q64099349-8B0069E3-D603-4C66-913E-1423A73DD8BDQ64243391-0C929D38-9462-4E7A-AAA4-9CBA328056E8Q74341083-97D27083-8959-46D3-ACE3-AD286B0AA122Q79251505-F6648CA3-64FB-495E-BFB2-9BD944611F8EQ81820583-24B10C82-2D5A-4546-9F7C-BE1116DA2D03Q89264310-91A1EFE2-4FE4-43BD-95F8-4FBF4F87F749Q91333660-354F7ABC-AAA6-4204-90E9-EA2B69878B9DQ92125098-C761864B-B7DA-4E15-A9DF-EFFF12719FB9Q92229034-35E50145-1DEA-4B3B-A893-6F41A1E5B649Q95841159-3379EA91-A4E8-4D73-AEDA-255208C7E37B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna Coppa
@ast
Anna Coppa
@en
Anna Coppa
@es
Anna Coppa
@nl
type
label
Anna Coppa
@ast
Anna Coppa
@en
Anna Coppa
@es
Anna Coppa
@nl
prefLabel
Anna Coppa
@ast
Anna Coppa
@en
Anna Coppa
@es
Anna Coppa
@nl
P106
P1153
7003606768
P31
P496
0000-0001-9758-5444